Work

A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)

Year: 2019

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.09.079

Authors: Melissa Alsina, C. Ola Landgren, Noopur Raje, Ruben Niesvizky, William I. Bensinger, Jesus Berdeja, Tibor Kovacsovics, David Vesole, Belle Fang, Amy Kimball, David S. Siegel

Institutions: Moffitt Cancer Center, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, NewYork–Presbyterian Hospital, Weill Cornell Medical Center, Sarah Cannon, Huntsman Cancer Institute, Hackensack University Medical Center, Amgen (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980449023

FWCI: 0.178

Cites:

Cited by: 1

Related to: 10